I've been buying NAL from 62c to 57c today. Would any current...

I've been buying NAL from 62c to 57c today. Would any current holders or previous holders of the stock care to comment where to from here for the share price. The company appears fundamentally sound with their holding in Norwood Immunology, cash and expected 2nd half revenue from Eyecare. Additionally the eminent physicians/directors and US hospitals involved in the US trials are worlds best.

I regret if this sounds like a ramp but I would imagine that Norwood Abbey at these prices or lower could prove a tempting target for a couple of Australian or any one of a number overseas Bio/Pharma companies.

Anyone care to comment?